OPKO Health Long Term Debt 2010-2024 | OPK

OPKO Health long term debt from 2010 to 2024. Long term debt can be defined as the sum of all long term debt fields.
OPKO Health Annual Long Term Debt
(Millions of US $)
2023 $214
2022 $210
2021 $188
2020 $222
2019 $211
2018 $57
2017 $29
2016 $44
2015 $49
2014 $131
2013 $212
2012 $
2011 $25
2010 $
2009 $15
OPKO Health Quarterly Long Term Debt
(Millions of US $)
2024-03-31 $344
2023-12-31 $242
2023-09-30 $213
2023-06-30 $212
2023-03-31 $211
2022-12-31 $210
2022-09-30 $142
2022-06-30 $211
2022-03-31 $211
2021-12-31 $188
2021-09-30 $186
2021-06-30 $183
2021-03-31 $225
2020-12-31 $222
2020-09-30 $219
2020-06-30 $216
2020-03-31 $214
2019-12-31 $211
2019-09-30 $209
2019-06-30 $206
2019-03-31 $204
2018-12-31 $57
2018-09-30 $57
2018-06-30 $56
2018-03-31 $55
2017-12-31 $29
2017-09-30 $29
2017-06-30 $35
2017-03-31 $39
2016-12-31 $44
2016-09-30 $52
2016-06-30 $45
2016-03-31 $50
2015-12-31 $49
2015-09-30 $44
2015-06-30 $109
2015-03-31 $107
2014-12-31 $131
2014-09-30 $115
2014-06-30 $116
2014-03-31 $225
2013-12-31 $212
2013-09-30 $209
2013-06-30 $189
2013-03-31 $276
2012-12-31
2012-09-30 $33
2012-06-30 $23
2012-03-31 $22
2011-12-31 $25
2011-09-30 $2
2011-06-30 $2
2011-03-31 $2
2010-12-31
2010-09-30
2010-06-30
2010-03-31
2009-12-31 $15
2009-09-30 $15
2009-06-30 $14
2009-03-31 $14
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $0.871B $0.864B
OPKO Health, Inc engages in the diagnostics and pharmaceuticals business in the United States, Ireland, Chile, Spain, Israel and Mexico. The Diagnostics segment operates Bio-Reference Laboratories, a clinical facility that offers testing services in the detection, diagnosis, evaluation, monitoring and treatment of diseases. The company's pharmaceutical business features Rayaldee, an FDA-approved treatment for secondary hyperparathyroidism (SHPT) in adults with stage 3 or 4 chronic kidney disease (CKD) and vitamin D insufficiency and VARUBI for chemotherapy induced nausea and vomiting. OPKO Health has a development and commercial supply pharmaceutical unit in Ireland along with a global supply chain operation and holding wing. The company also owns specialty active pharmaceutical ingredients (APIs) manufacturer in Israel.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $218.361B 26.46
Intuitive Surgical (ISRG) United States $151.024B 90.98
Edwards Lifesciences (EW) United States $52.601B 34.23
DexCom (DXCM) United States $46.111B 69.85
Alcon (ALC) Switzerland $44.714B 32.04
IDEXX Laboratories (IDXX) United States $41.624B 48.79
IQVIA Holdings (IQV) United States $38.763B 22.49
STERIS (STE) Ireland $21.579B 25.21
SONOVA HOLDING (SONVY) Switzerland $18.556B 0.00
Waters (WAT) United States $17.496B 25.71
Hologic (HOLX) United States $16.754B 18.74
Fresenius Medical Care AG KGaA (FMS) Germany $12.100B 14.12
Sysmex ADR (SSMXY) Japan $9.900B 31.05
Teleflex (TFX) United States $9.811B 15.27
Globus Medical (GMED) United States $8.882B 26.04
Penumbra (PEN) United States $7.279B 82.72
Masimo (MASI) United States $7.203B 41.49
Glaukos (GKOS) United States $5.671B 0.00
TransMedics (TMDX) United States $4.677B 443.78
Integer Holdings (ITGR) United States $3.897B 23.55
PROCEPT BioRobotics (PRCT) United States $3.248B 0.00
Tandem Diabetes Care (TNDM) United States $2.928B 0.00
LivaNova (LIVN) United Kingdom $2.853B 16.94
Inari Medical (NARI) United States $2.634B 0.00
Nihon Kohden (NHNKY) Japan $2.601B 13.78
Elekta AB (EKTAY) Sweden $2.365B 18.13
Integra LifeSciences Holdings (IART) United States $2.305B 10.05
RxSight (RXST) United States $2.141B 0.00
Veracyte (VCYT) United States $1.603B 0.00
Alphatec Holdings (ATEC) United States $1.491B 0.00
Artivion (AORT) United States $0.964B 92.48
AVANOS MEDICAL, INC (AVNS) United States $0.883B 17.18
Silk Road Medical (SILK) United States $0.844B 0.00
OrthoPediatrics (KIDS) United States $0.698B 0.00
Pulse Biosciences (PLSE) United States $0.664B 0.00
IRadimed (IRMD) United States $0.548B 30.67
SiBone (SIBN) United States $0.522B 0.00
Paragon 28 (FNA) United States $0.510B 0.00
Mesa Laboratories (MLAB) United States $0.494B 14.66
Pacific Biosciences Of California (PACB) United States $0.479B 0.00
ORTHOFIX MEDICAL INC (OFIX) United States $0.465B 0.00
Treace Medical Concepts (TMCI) United States $0.375B 0.00
AxoGen (AXGN) United States $0.334B 0.00
Nevro (NVRO) United States $0.332B 0.00
Sight Sciences (SGHT) United States $0.326B 0.00
Tactile Systems Technology (TCMD) United States $0.280B 9.58
Semler Scientific (SMLR) United States $0.271B 13.73
AngioDynamics (ANGO) United States $0.246B 0.00
CVRx (CVRX) United States $0.220B 0.00
Delcath Systems (DCTH) United States $0.212B 0.00
908 Devices (MASS) United States $0.200B 0.00
EDAP TMS S.A (EDAP) France $0.200B 0.00
NeuroPace (NPCE) United States $0.186B 0.00
Inogen (INGN) United States $0.172B 0.00
Accuray (ARAY) United States $0.172B 0.00
Alpha Tau Medical (DRTS) Israel $0.160B 0.00
Atossa Genetics (ATOS) United States $0.151B 0.00
ClearPoint Neuro (CLPT) United States $0.148B 0.00
Yubo Biotech (YBGJ) China $0.123B 0.00
Spectral Diagnostics (EDTXF) Canada $0.101B 0.00
KORU Medical Systems (KRMD) United States $0.098B 0.00
Sensus Healthcare (SRTS) United States $0.087B 18.28
Monogram Orthopaedics (MGRM) United States $0.065B 0.00
EnVVeno Medical (NVNO) United States $0.064B 0.00
InspireMD (NSPR) Israel $0.063B 0.00
Hyperfine (HYPR) United States $0.063B 0.00
Neuronetics (STIM) United States $0.061B 0.00
SEP Acquisition (SEPA) United States $0.055B 0.00
LENSAR (LNSR) United States $0.053B 0.00
Envoy Medical (COCH) United States $0.051B 0.00
T2 Biosystems (TTOO) United States $0.045B 0.00
Vicarious Surgical (RBOT) United States $0.040B 0.00
Lucid Diagnostics (LUCD) United States $0.039B 0.00
ReWalk Robotics (LFWD) Israel $0.039B 0.00
Precision Optics (POCI) United States $0.037B 0.00
DarioHealth (DRIO) United States $0.035B 0.00
Rapid Micro Biosystems (RPID) United States $0.033B 0.00
Accelerate Diagnostics (AXDX) United States $0.030B 0.00
Spectral AI (MDAI) United States $0.028B 0.00
Autonomix Medical (AMIX) United States $0.028B 0.00
Pixie Dust Technologies (PXDT) Japan $0.026B 0.00
Aspira Women's Health (AWH) United States $0.025B 0.00
Inspira Technologies OXY B.H.N (IINN) Israel $0.024B 0.00
Ekso Bionics Holdings (EKSO) United States $0.019B 0.00
QT Imaging Holdings (QTI) United States $0.016B 0.00
Microbot Medical (MBOT) United States $0.016B 0.00
NexGel (NXGL) United States $0.014B 0.00
Check-Cap (CHEK) Israel $0.013B 0.00
PAVmed (PAVM) United States $0.010B 0.00
Venus Concept (VERO) Canada $0.006B 0.00
Nuwellis (NUWE) United States $0.004B 0.00
Helius Medical Technologies (HSDT) United States $0.003B 0.00
Avinger (AVGR) United States $0.003B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.003B 0.00
ReShape Lifesciences (RSLS) United States $0.003B 0.00
Tenon Medical (TNON) United States $0.002B 0.00
Nanovibronix (NAOV) United States $0.002B 0.00
Dynatronics (DYNT) United States $0.002B 0.00
Bluejay Diagnostics (BJDX) United States $0.001B 0.00
ENDRA Life Sciences (NDRA) United States $0.001B 0.00
Longview Acquisition II (LGV) United States $0.000B 0.00
Spinal Elements Holdings (SPEL) United States $0.000B 0.00